首页> 美国卫生研究院文献>British Medical Journal >Clinical effectiveness of treatment with hyperbaric oxygen for neonatal hypoxic-ischaemic encephalopathy: systematic review of Chinese literature
【2h】

Clinical effectiveness of treatment with hyperbaric oxygen for neonatal hypoxic-ischaemic encephalopathy: systematic review of Chinese literature

机译:高压氧治疗新生儿缺氧缺血性脑病的临床疗效:中国文献综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objectives To investigate the clinical effectiveness of treatment with hyperbaric oxygen for neonates with hypoxic-ischaemic encephalopathy. This treatment is frequently used in China but much less often in the West.>Data sources Western (Cochrane controlled trials register and database of systematic reviews, Medline, Embase, CINAHL, and HealthSTAR) and Chinese (China Hospital Digital Library, Chinese Medical Journal Network) databases and hand search of Chinese journals. No language restrictions.>Review methods Randomised or quasi-randomised controlled trials of treatment with hyperbaric oxygen compared with “usual care” in term neonates with hypoxic-ischaemic encephalopathy. Outcomes included mortality and long term neurological sequelae. Standardised forms were used to extract and compare data. Criteria of York Centre for Reviews and Dissemination were used to assess quality. Analysis was mainly qualitative but included meta-analysis.>Results 20 trials were found, mainly from Chinese sources. The reporting quality of trials was poor by Western (CONSORT) standards. Treatment with hyperbaric oxygen had better outcomes than the comparator in almost all trials. The odds ratios of the meta-analyses were 0.26 (95% confidence interval 0.14 to 0.46) for mortality and 0.41 (0.27 to 0.61) for neurological sequelae.>Conclusion Treatment with hyperbaric oxygen possibly reduces mortality and neurological sequelae in term neonates with hypoxic-ischaemic encephalopathy. Because of the poor quality of reporting in all trials and the possibility of publication bias, an adequately powered, high quality randomised controlled trial is needed to investigate these findings. The Chinese medical literature may be a rich source of evidence to inform clinical practice and other systematic reviews.
机译:>目的探讨高压氧治疗新生儿缺氧缺血性脑病的临床疗效。这种疗法在中国经常使用,而在西方国家则很少。>数据来源西方人(Cochrane对照试验注册和系统评价数据库,Medline,Embase,CINAHL和HealthSTAR)和中国人(中国医院)数字图书馆,中国医学期刊网络)数据库和对中文期刊的手工搜索。没有语言限制。>审查方法在低氧缺血性脑病足月新生儿中进行高压氧治疗与“常规治疗”相比的随机或半随机对照试验。结果包括死亡率和长期神经系统后遗症。标准化表格用于提取和比较数据。约克审查与传播中心的标准用于评估质量。分析主要是定性的,但包括荟萃分析。>结果发现了20项试验,主要来自中国。根据西方(CONSORT)标准,试验报告的质量较差。在几乎所有试验中,高压氧治疗均优于比较者。荟萃分析的死亡率比值为0.26(95%置信区间0.14至0.46),神经系统后遗症的比值比为0.41(0.27至0.61)。>结论高压氧治疗可能会降低死亡率和神经系统后遗症。足月新生儿缺氧缺血性脑病。由于所有试验中报告的质量较差以及发表偏见的可能性,因此需要有足够的能力,高质量的随机对照试验来研究这些发现。中国医学文献可能是丰富的证据,可为临床实践和其他系统评价提供参考。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号